Current Knowledge of Vaccinations in Chronic Kidney Disease Patients

References

• Snigdha R, Chandrika C, Jerry Y. Vaccination in Chronic Kidney Disease. Adv Chronic Kidney Dis. 2019;26(1):72–78. doi:10.1053/j.ackd.2018.10.00230876620
   PubMed Web of Science ®Google Scholar
• Naqvi SB, Collins AJ. Infectious complications in Chronic Kidney Disease. Adv Chronic Kidney Dis. 2006;13(3):199–204. doi:10.1053/j.ackd.2006.04.00416815225
   PubMed Web of Science ®Google Scholar
• Kosmadakis G, Albaret J. Enrique Da Costa Correia, Frederic Somda, Didier Aguilera. Vaccination practices in dialysis patients: A narrative review. Semin Dial. 2018;1–12.
   Web of Science ®Google Scholar
• Lee Ventola C. Immunization in the United States: recommendations, barriers, and measures to improve compliance. part 2: adult vaccinations. Pharm Ther. 2016;41(8):P&T.
   Google Scholar
• Annunziata K, Rak A, Del Buono H, et al. Vaccination rates among the general adult popula- tion and high-risk groups in the United States. PLoS One. 2012;7(11):e50553. doi:10.1371/journal.pone.005055323226312
   PubMed Web of Science ®Google Scholar
• Bitsori M, Galanakis E. Vaccine-preventable infection morbidity of patients with chronic kidney disease and cocoon cination strategies, expert review of vaccines. Expert Rev Vaccines. 2015;14(10):1385–1395. doi:10.1586/14760584.2015.107539726289972
   PubMed Web of Science ®Google Scholar
• Kato S, Chmielewski M, Honda H, et al. Aspects of immune dysfunction in end-stage renal disease. Clin J Am Soc Nephrol. 2008;3(5):1526–1533. doi:10.2215/CJN.0095020818701615
   PubMed Web of Science ®Google Scholar
• Ishigami J, Matsushita K. Clinical epidemiology of infectious disease among patients with chronic kidney disease. Clin Exp Nephrol. 2019;23(4):437–447. doi:10.1007/s10157-018-1641-830178234
   PubMed Web of Science ®Google Scholar
• Litjens NH, van Druningen CJ, Betjes MG. Progressive loss of renal function is associated with activation and depletion of naive T lymphocytes. Clin Immunol. 2006;118(1):83–91. doi:10.1016/j.clim.2005.09.00716257266
   PubMed Web of Science ®Google Scholar
• Meier P, Dayer E, Blanc E, Wauters JP. Early T cell activation correlates with expression of apoptosis markers in patients with end-stage renal disease. J Am Soc Nephrol. 2002;13(1):204–212.11752039
   PubMed Web of Science ®Google Scholar
• Anding K, Gross P, Rost JM. The influence of uraemia and haemodialysis on neutrophil phagocytosis and antimicrobial killing. Nephrol Dial Transplant. 2003;18(10):2067–2073. doi:10.1093/ndt/gfg33013679482
   PubMed Web of Science ®Google Scholar
• Gollapudi P, Yoon JW, Gollapudi S. Leukocyte toll-like receptor expression in end-stage kidney disease. Am J Nephrol. 2010;31(3):247–254. doi:10.1159/00027676420090311
   PubMed Web of Science ®Google Scholar
• sela S, Shurtz-Swirski R, Cohen-Mazor M, et al. Primed peripheral polymorphonuclear leukocyte: a culprit underlying chronic low-grade inflammation and systemic oxidative stress in chronic kidney disease. J Am Soc Nephrol. 2005;16(8):2431–2438. doi:10.1681/ASN.200411092915987755
   PubMed Web of Science ®Google Scholar
• Maverakis E, Kim K, Shimoda M, et al. Glycans in the immune system and the altered gly- can theory of autoimmunity: a critical review. J Autoimmun. 2015;57:1–13. doi:10.1016/j.jaut.2014.12.00225578468
   PubMed Web of Science ®Google Scholar
• Schmidt EP, Yang Y, Janssen WJ, et al. The pulmonary endothelial glycocalyx regulates neutrophil adhesion and lung injury during experimental sepsis. Nat Med. 2012;18(8):1217–1223. doi:10.1038/nm.284322820644
   PubMed Web of Science ®Google Scholar
• Bazzoni G, Dejana E. Endothelial cell-to-cell junctions: molecu- lar organization and role in vascular homeostasis. Physiol Rev. 2004;84(3):869–901. doi:10.1152/physrev.00035.200315269339
   PubMed Web of Science ®Google Scholar
• Landray MJ, Wheeler DC, Lip GY, et al. Inflammation, endothelial dysfunction, and platelet activation in patients with chronic kidney disease: the chronic renal impairment in Birmingham (CRIB) study. Am J Kidney Dis. 2004;43(2):244–253. doi:10.1053/j.ajkd.2003.10.03714750089
   PubMed Web of Science ®Google Scholar
• Guidelines for vaccinating kidney dialysis patients and patients with chronic kidney disease summarized from recommendations of the Advisory Committee on Immunization Practices (ACIP); 2012 Available from: https://www.cdc.gov/vaccines/pubs/dialysis-guide-2012.pdf.
   Google Scholar
• Danziger-Isakov L, Kumar D. AST Infectious diseases community of practice. Vaccination in solid organ transplantation. Am J Transplant. 2013;13(Suppl 4):311–317. doi:10.1111/ajt.1212223465023
   PubMed Web of Science ®Google Scholar
• Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 2012;2013(Suppl 3):1–150.
   Google Scholar
• Preboth M. PHS guidelines for management of occupational expo- sure to HBV, HCV and HIV: management of occupational blood exposures. Am Fam Physician. 2001;64(12):2012–2014.11775767
   PubMed Web of Science ®Google Scholar
• Edey M, Barraclough K, Johnson DW. Review article: hepatitis B and dialysis. Nephrology. 2010;15(2):137–145. doi:10.1111/j.1440-1797.2009.01268.x20470270
   PubMed Web of Science ®Google Scholar
• Mast EE, Margolis HS, Fiore AE, et al. A comprehensive immuniza- tion strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents. MMWR Recommend Rep. 2005;54(RR16):1–31.
   Google Scholar
• DaRoza G, Loewen A, Djurdjev O, et al. Stage of chronic kidney disease predicts seroconversion after hepatitis B immunization: earlier is better. Am J Kidney Dis. 2003;42:1184–1192. doi:10.1053/j.ajkd.2003.08.01914655190
   PubMed Web of Science ®Google Scholar
• Burdick RA, Bragg-Gresham JL, Woods JD, et al. Patterns of hepatitis B prevalence and seroconversion in hemodialysis units from three continents: the DOPPS. Kidney Int. 2003;63:2222–2229. doi:10.1046/j.1523-1755.2003.00017.x12753311
   PubMed Web of Science ®Google Scholar
• A two-dose hepatitis B vaccine for adults (Heplisav-B). JAMA. 2018;319(8):822–823. doi:10.1001/jama.2018.109729486033
   PubMed Web of Science ®Google Scholar
• Barraclough KA, Wiggins KJ, Hawley CM, et al. Intradermal versus intramuscular hepatitis B vaccination in hemodialysis patients: a prospective open-label randomized controlled trial in nonresponders to primary vaccination. Am J Kidney Dis. 2009;54:95–103. doi:10.1053/j.ajkd.2009.03.01019481320
   PubMed Web of Science ®Google Scholar
• Micozkadioglu H, Zumrutdal A, Torun D, Sezer S, Ozdemir FN, Haberal M. Low dose intradermal vaccination is superior to high dose intramuscular vaccination for hepatitis B in unresponsive hemodialysis patients. Ren Fail. 2007;29:285–288. doi:10.1080/0886022060116626317497441
   PubMed Web of Science ®Google Scholar
• Rubin LG, Levin MJ, Ljungman P, et al. Infectious Diseases Society of America. 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis. 2014;58:e44100.
   Web of Science ®Google Scholar
• Fabrizi F, Martin P, Messa P. Novel perspectives on the hepatitis B virus vaccine in the chronic kidney disease population. Int J Artif Organs. 2015;38:625–631. doi:10.5301/ijao.500045826821784
   PubMed Web of Science ®Google Scholar
• Mulley WR, Le ST, Ives KE. Primary seroresponses to double-dose compared with standard-dose hepatitis B vaccination in patients with chronic kidney disease: a systematic review and meta-analysis. Nephrol Dial Transplant. 2017;32:136–143. doi:10.1093/ndt/gfv44326763670
   PubMed Web of Science ®Google Scholar
• Ong KY, Wong HY, Khee GY. What is the hepatitis B vaccination regimen in chronic kidney disease? Cleve Clin J Med. 2018;85(1):32–34. doi:10.3949/ccjm.85a.1701729328895
   PubMed Web of Science ®Google Scholar
• Kim DK, Riley LE, Hunter P. on behalf of the Advisory Committee on Immunization Practices. recommended immunization schedule for adults aged 19 years or older, united states, 2018. Ann Intern Med. 2018;168(3):210–220. doi:10.7326/M17-343929404596
   PubMed Web of Science ®Google Scholar
• European Consensus Group on Hepatitis B Immunity: are booster immunizations needed for lifelong hepatitis B immunity? Lancet. 2000;355:561–565. doi:10.1016/S0140-6736(99)07239-610683019
   PubMed Web of Science ®Google Scholar
• Wang IK, Lin CL, Lin PC, et al. Effectiveness of influenza vaccination in patients with end-stage renal disease receiving hemodialysis: a population-based study. PLoS One. 2013;8(3):e58317. doi:10.1371/journal.pone.005831723516462
   PubMed Web of Science ®Google Scholar
• Bosaeed M, Kumar D. Seasonal influenza vaccine in immunocompromised persons. Hum Vaccin Immunother. 2018;14(6):1311–1322. doi:10.1080/21645515.2018.144544629485353
   PubMed Web of Science ®Google Scholar
• Gilbertson DT, Unruh M, McBean AM, et al. Influenza vaccine delivery and effectiveness in end- stage renal disease. Kidney Int. 2003;63(2):738–743. doi:10.1046/j.1523-1755.2003.00787.x12631142
   PubMed Web of Science ®Google Scholar
• Kumar D, Blumberg EA, Danziger-Isakov L, et al. Influenza vaccination in the organ transplant recipient: review and summary recom- mendations. Am J Transplant. 2011;11(10):2020–2030. doi:10.1111/j.1600-6143.2011.03753.x21957936
   PubMed Web of Science ®Google Scholar
• Grohskopf LA, Sokolow LZ, Broder KR, et al. Prevention and control of seasonal influenza with vaccines: recommendations of the advisory committee on immunization practices United States, 2017–18 Influenza Season. MMWR Recomm Rep. 2017;66:1–20. doi:10.15585/mmwr.rr6602a1
   PubMed Web of Science ®Google Scholar
• Remschmidt C, Wichmann O, Harder T. Methodological quality of systematic reviews on influenza vaccination. Vaccine. 2014;32:1678–1684. doi:10.1016/j.vaccine.2014.01.06024513008
   PubMed Web of Science ®Google Scholar
• Song JY, Cheong HJ, Ha SH, Kee SY, Jeong HW, Kim WJ. Active influenza immunization in hemodialysis patients: comparison between single-dose and booster vaccination. Am J Nephrol. 2006;26:206–211. doi:10.1159/00009330616699258
   PubMed Web of Science ®Google Scholar
• Sarnak MJ, Jaber BL. Pulmonary infectious mortality among patients with end-stage renal disease. Chest. 2001;120:1883–1887. doi:10.1378/chest.120.6.188311742917
   PubMed Web of Science ®Google Scholar
• Vandecasteele SJ, Ombelet S, Blumental S, Peetermans WE. The ABC of pneumococcal infections and vaccination in patients with chronic kidney disease. Clin Kidney J. 2015;8(3):318–324. doi:10.1093/ckj/sfv03026034594
   PubMedGoogle Scholar
• Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocom- promising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morbidity Mortality Weekly Rep. 2012;61(40):816–819.
   PubMedGoogle Scholar
• Tomczyk S, Bennett NM, Stoecker C, et al. Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged >/=65 years: recommendations of the advisory committee on immunization practices (ACIP). MMWR Morb Mortal Wkly Rep. 2014;63:822–825.25233284
   PubMed Web of Science ®Google Scholar
• Portoles-Perez J, Marques-Vidas M, Picazo JJ, et al. Recommendations for vaccination against pneumococcus in kidney patients in Spain. Nefrologia. 2014;34:545–551. doi:10.3265/Nefrologia.pre2014.May.1253425036264
   PubMed Web of Science ®Google Scholar
• Haut Conseil de la Santé publique, France. Avis relatif aux recommandations Vaccinales contre les infections a pneumocoque pour les adultes. Haut Conseil de la Santé Publique:France;1–13. 103 2017.
   Google Scholar
• Sagheb MM, Sajjadi S, Sajjady G. A study on the protection of hemodialysis patients against diphtheria and tetanus. Ren Fail. 2009;31:904–909. doi:10.3109/0886022090326835320030525
   PubMed Web of Science ®Google Scholar
• Mathew R, Mason D, Kennedy JS. Vaccination issues in patients with chronic kidney disease. Expert Rev Vaccin. 2014;13(2):285–298. doi:10.1586/14760584.2014.874950
   PubMed Web of Science ®Google Scholar
• Ventola CL. Immunization in the United States: recommendations, barriers, and measures to improve compliance. Part 2: adult vaccinations. P T. 2016;41(8):492–506.27504066
   PubMedGoogle Scholar
• Lin KY, Chen GJ, Lee YL, et al. Hepatitis A virus infection and hepatitis A vaccination in human immunodeficiency virus-positive patients: A review. World J Gastroenterol. 2017;23(20):3589–3606. doi:10.3748/wjg.v23.i20.358928611512
   PubMed Web of Science ®Google Scholar
• Craig AS, Watson B, Zink TK, et al. Hepatitis A outbreak activity in the United States: responding to a vaccine-preventable disease. Am J Med Sci. 2007;334(3):180–183. doi:10.1097/MAJ.0b013e318142541117873531
   PubMed Web of Science ®Google Scholar
• Gunawansa N, Rathore R, Sharma A, Halawa A. Vaccination practices in end stage renal failure and renal transplantation; review of current guidelines and recommendations. World J Transpl. 2018;8(3):68–74. doi:10.5500/wjt.v8.i3.68
   Google Scholar
• DeVault KR, Wallace MB, Aqel BA, Keith D. Practical Gastroenterology and Hepatology Board Review Toolkit. Lindor‬ John Wiley & Sons; 2016 9 26:680
   Google Scholar
• Fleischmann EH, Kruppenbacher J, Bock HL, et al. Active immunization against hepatitis A in dialysis patients. Nephrol Dial Transplant. 2002;17:1825–1828. doi:10.1093/ndt/17.10.182512270992
   PubMed Web of Science ®Google Scholar
• Dooling KL, Guo A, Patel M, et al. Recommendations of the advisory committee on immunization practices for use of herpes zoster vaccines. MMWR Morb Mortal Wkly Rep. 2018;67:103–108. doi:10.15585/mmwr.mm6703a529370152
   PubMed Web of Science ®Google Scholar
• Gabutti G, Bolognesi N, Sandri F, Florescu C, Stefanati A. Varicella zoster virus vaccines: an update. Immunotargets Ther. 2019;8:15–28. doi:10.2147/ITT.S17638331497569
   PubMed Web of Science ®Google Scholar
• McLean HQ, Fiebelkorn AP, Temte JL, Wallace GS. Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2013;62(RR04):1–34.
   Google Scholar
• Kim YJ, Kim SI. Vaccination strategies in patients with solid organ transplant: evidences and future perspectives. Clin Exp Vaccine Res. 2016;5(2):125–131. doi:10.7774/cevr.2016.5.2.12527489802
   PubMedGoogle Scholar